Several studies performed in different tumor models, including breast, pancreatic, colon, endometrial, ovarian and lung cancer, demonstrated the ability of MET to inhibit tumor cell proliferation, both as monotherapy or in combination with chemo- and radiotherapy [15,16,17]. The gene discussed is MET; the disease is neoplasm.